Incentives for research on neglected disease

被引：0
|
作者：
Kremer, M [1 ]
Glennerster, R
机构：
[1] Harvard Univ, Dept Econ, Littauer Ctr 207, Cambridge, MA 02138 USA
[2] MIT, Poverty Act Lab, Cambridge, MA 02139 USA
来源：
LANCET | 2005年 / 365卷 / 9461期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：753 / 754
页数：2
相关论文
共 50 条
  • [21] New neglected disease research scheme pools IP and expertise
    Frantz, Simon
    NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (01) : 5 - 5
  • [22] Spending on research into neglected disease reached record high in 2017
    Wise, Jacqui
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 364 : l303
  • [23] Tabanids: Neglected subjects of research, but important vectors of disease agents!
    Baldacchino, Frederic
    Desquesnes, Marc
    Mihok, Steve
    Foil, Lane D.
    Duvallet, Gerard
    Jittapalapong, Sathaporn
    INFECTION GENETICS AND EVOLUTION, 2014, 28 : 596 - 615
  • [24] Global Monkeypox Outbreaks Spur Drug Research for the Neglected Disease
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (03): : 231 - 233
  • [25] Neglected tropical disease research: rethinking the drug discovery model
    Coaker, Hannah
    Bombelles, Thomas
    Todd, Matthew
    Dent, Jennifer
    Fine, Jacqueline
    Olsen, David
    Gustavsen, Ken
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (06) : 693 - 700
  • [26] Research incentives and research output
    Finn Jørgensen
    Thor-Erik Sandberg Hanssen
    Higher Education, 2018, 76 : 1029 - 1049
  • [27] Research incentives and research output
    Jorgensen, Finn
    Hanssen, Thor-Erik Sandberg
    HIGHER EDUCATION, 2018, 76 (06) : 1029 - 1049
  • [28] Incentives for Starting Small Companies Focused on Rare and Neglected Diseases
    Ekins, Sean
    Wood, Jill
    PHARMACEUTICAL RESEARCH, 2016, 33 (04) : 809 - 815
  • [29] Incentives for Starting Small Companies Focused on Rare and Neglected Diseases
    Sean Ekins
    Jill Wood
    Pharmaceutical Research, 2016, 33 : 809 - 815
  • [30] Proposal ties financial incentives to development of drugs for neglected diseases
    Young, D
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (08) : 694 - +
12345